Sharing international experience in CKD & SGLT2i: How to identify the right patient at the right moment?
Meeting report with presentation slides, videos and online CME of the EBAC-accredited symposium held at WCN’23, Bangkok, Thailand.
1-5 of 5
- Sharing international experience in CKD & SGLT2i: How to identify the right patient at the right moment?Initiation of SGLT2i in CKD: how, when and who?
David Cherney, MD, PhD
Roberto Pecoits-Filho, MD, PhD
Magdalena Madero, MD
- Sharing international experience in CKD & SGLT2i: How to identify the right patient at the right moment?Meta-analysis of the effects of SGLT2i on kidney outcomes
Natalie Staplin, PhD
- Sharing international experience in CKD & SGLT2i: How to identify the right patient at the right moment?SGLT2i in the spectrum of CKD: A call for action
Meg Jardine, MD, PhD
- Sharing international experience in CKD & SGLT2i: How to identify the right patient at the right moment?The latest evidence of SGLT2i in CKD
Will Herrington, MD
- Sharing international experience in CKD & SGLT2i: How to identify the right patient at the right moment?New opportunities to tackle the global burden of CKD – the role of SGLT2i
Adeera Levin, MD
